2024 |
---|
Feichtenschlager, V., Chen, L., Zheng, Y. J., Ho, W., Sanlorenzo, M., Vujic, I., Fewings, E., Et Al, ., Kohwi, Y., Posch, C., Rappersberger, K., Kohwi-Shigematsu, T., Coppe, J. P., & Ortiz-Urda, S. (2024). The therapeutically actionable long non-coding RNA ' T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma. Res Sq, 23(1), 40. doi: 10.21203/rs.3.rs-1297358/v3 (IF: 37.3) |
Richtig, E., Nguyen, V. A., Koelblinger, P., Wolf, I., Kehrer, H., Et Al, ., Weihsengruber, F., Rappersberger, K., Svastics, N., Gasser, K., Seeber, A., Kratochvill, F., Nagler, S., Mraz, B., & Hoeller, C. (2024). Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial. Melanoma Res, 34(2), 142-151. doi: 10.1097/CMR.0000000000000948 (IF: 2.2) |
Wiala, A., Daschl, S. M., Stockinger, T., Rappersberger, K., & Posch, C. (2024). Oral fusidic acid for the treatment of mild-to-moderate hidradenitis suppurativa. Int J Dermatol, -(-), -. doi: 10.1111/ijd.17115 (IF: 3.6) |
2023 |
Feichtenschlager, V., Chen, L., Zheng, Y. J., Ho, W., Sanlorenzo, M., Vujic, I., Fewings, E., Lee, A., Chen, C., Et Al, ., Posch, C., Daud, A., Rappersberger, K., Kohwi-Shigemtsu, T., Coppé, J. P., & Ortiz-Urda, S. (2023). The therapeutically actionable long non-coding RNA ' T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma. Res Sq, -(-), -. doi: 10.21203/rs.3.rs-1297358/v3 |
Feichtenschlager, V., Zheng, Y. J., Ho, W., Chen, L., Callanan, C., Lee, A., Ortiz, J., Rappersberger, K., & Ortiz-Urda, S. (2023). Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment. Oncotarget, -(-), 543-560. doi: 10.18632/oncotarget.28447 |
Wiala, A., Rappersberger, K., & Monshi, B. (2023). The role of histopathology in a case of adult-onset linear cutaneous lupus. J Dtsch Dermatol Ges, 21(1), 66-68. doi: 10.1111/ddg.14928 (IF: 3.9) |
Wiala, A., Rappersberger, K., & Monshi, B. A. (2023). Die Rolle der Histopathologie in einem Fall von linearem kutanem Lupus im Erwachsenenalter. J Dtsch Dermatol Ges, 21(1), 66-68. doi: 10.1111/ddg.14928_g (IF: 3.9) |
2022 |
Perschy, L., Anzengruber, F., Rappersberger, K., Itzlinger-Monshi, B., Aichelburg, M. C., Graf, V., Hafner, J., & Vujic, I. (2022). Apremilast bei oralem Lichen planus - eine multizentrische, retrospektive Studie. J Dtsch Dermatol Ges, 20(3), 343-348. doi: 10.1111/ddg.14696_g |
Zheng, Y. J., Ho, W., Sanlorenzo, M., Vujic, I., Daud, A., Algazi, A., Rappersberger, K., & Ortiz-Urda, S. (2022). Melanoma risk during immunomodulating treatment. Melanoma Res, 32(6), 411-418. doi: 10.1097/CMR.0000000000000838 |
2021 |
Kirchler, C., Husar-Memmer, E., Rappersberger, K., Thaler, K., & Fritsch-Stork, R. (2021). Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review. Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review, 20(5), 102794. doi: 10.1016/j.autrev.2021.102794 |
Monshi, B., Ellersdrofer, C., Edelmayer, M., Dvorak, G., Ganger, C., Ulm, C., Rappersberger, K., & Vujic, I. (2021). Department of Dermatology and Venereology, Klinik Landstraße, Juchgasse 25, 1030 Vienna, Austria. J Clin Med, 10(22), 5454. doi: 10.3390/jcm10225454 |
Monshi, B., Grabovac, S., Gulz, L., Ellersdorfer, C., Vujic, M., Richter, L., Kivaranovic, D., Rappersberger, K., & Vujic, I. (2021). Psoriasis is associated with fissured tongue but not geographic tongue: a prospective, cross-sectional, case-control study. J Dtsch Dermatol Ges, 19(8), 1170-1177. doi: 10.1111/ddg.14451 |
Monshi, B., Grabovac, S., Gulz, L., Ellersdorfer, C., Vujic, M., Richter, L., Kivaranovic, D., Rappersberger, K., & Vujic, I. (2021). Psoriasis ist mit Lingua plicata jedoch nicht mit Lingua geographica assoziiert: eine prospektive Fall-Kontroll-Studie. J Dtsch Dermatol Ges, 19(8), 1170-1177. doi: 10.1111/ddg.14451_g |
Schiffmann, M. L., Dissemond, J., Erfurt-Berge, C., Hafner, J., Itzlinger-Monshi, B. A., Jungkunz, H. W., Kahle, B., Kreuter, A., Scharffetter-Kochanek, K., Lutze, S., Rappersberger, K., Schneider, S. W., & Et Al, . (2021). S1-Leitlinie Diagnostik und Therapie der Livedovaskulopathie. J Dtsch Dermatol Ges, 19(11), 1667-1678. doi: 10.1111/ddg.14520_g |
Schiffmann, M. L., Dissemond, J., Erfurt-Berge, C., Hafner, J., Itzlinger-Monshi, B. A., Jungkunz, H. W., Kahle, B., Kreuter, A., Scharffetter-Kochanek, K., Lutze, S., Rappersberger, K., Schneider, S. W., Strölin, A., Sunderkötter, C., & Goerge, T. (2021). German S1 guideline: diagnosis and treatment of livedovasculopathy. N Dtsch Dermatol Ges, 19(11), 1668-1678. doi: 10.1111/ddg.14520 |
Wiala, A., Vujic, I., Richter, L., Rappersberger, K., & Posch, C. (2021). Dermatomyositis requires long-term treatment with combined immunosuppressive and immunoglobulin therapy. J Dtsch Dermatol Ges, 19(3), 456-458. doi: 10.1111/ddg.14365_g |
2020 |
Monshi, B., Gulz, L., Piringer, B., Wiala, A., Kivaranovic, D., Schmidt, M., Sesti, A., Heil, T., Vujic, I., Posch, C., & Rappersberger, K. (2020). Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid. J Eur Acad Dermatol Venereol, 34(7), 1583-1589. doi: 10.1111/jdv.16363 |
Vujic, I., Gandini, S., Stanganelli, I., Fierro, M. T., Rappersberger, K., Sibilia, M., Tosti, G., Ferrucci, P. F., Caini, S., De Felici, M. B., Pagliarello, C., Quaglino, P., Sanlorenzo, M., & Imi, T. I. M. I. (2020). A Meta-Analysis of Melanoma Risk in Industrial Workers. Melanoma Res., 30(3), 286-296. doi: 10.1097/CMR.0000000000000531 |
2019 |
Feichtenschlager, V., Weihsengruber, F., Richter, L., Vujic, I., Rappersberger, K., & Posch, C. (2019). Clinical melanoma characteristics and survival-a single-center retrospective study between 2000 and 2010. Wien Med Wochenschr, 169(13-14), 323-330. doi: 10.1007/s10354-018-0678-3 |
Grieb, A., Kaderschabek, N., Orasche, C., Minkov, M., Sanlorenzo, M., Rappersberger, K., & Vujic, I. (2019). Mycoplasma pneumoniae-associated mucositis with cutaneous involvement - a case report. J Dtsch Dermatol Ges, 17(2), 184-185. doi: 10.1111/ddg.13714 (IF: 3.9) |
Platzer, K. D., Kostner, L., Vujic, I., Monshi, B., Richter, L., Rappersberger, K., & Posch, C. (2019). Clinical characteristics and treatment outcomes of 36 pyoderma gangrenosum patients - a retrospective, single institution observation. J Eur Acad Dermatol Venereol, 33(7), Epub ahead of print. doi: 10.1111/jdv.15803 (IF: 4.287) |
2018 |
Sanlorenzo, M., Vujic, I., Esteve-Puig, R., Lin, K., Posch, C., Dimon, M., Moy, A., Zekhtser, M., Johnston, K., Gho, D., Ho, W., Gajjala, A., Oses Prieto, J., Burlingame, A., Daud, A., Rappersberger, K., & Ortz-Urda, S. (2018). The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma. Scientific Reports, 8(1), 10902. doi: 10.1038/s41598-018-27643-3 (IF: 4,12) |
2017 |
Bal, C., Rappersberger, K., & Posch, C. (2017). Adverse effects of subcutaneous, drug-releasing implants for the treatment of opioid drug addiction. J Dtsch Dermatol Ges, 15(12), 1232-1234. doi: 10.1111/ddg.13319 |
Kwong, A., Sanlorenzo, M., Rappersberger, K., & Vujic, I. (2017). Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies. Wien Klin Wochenschrift, pp(1-9), epub. doi: 10.1007/s10354-016-0535-1 |
Posch, C., Monshi, B., Quint, T., Vujic, I., Lilgenau, N., & Rappersberger, K. (2017). The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients. J Am Acad Dermatol, 77(1), 123-129. doi: 10.1016/j.jaad.2017.01.055 |